BLND vs PACB
Comparison between Blend Labs Inc - Class A (BLND, Company) and Pacific Biosciences of California Inc (PACB, Company).
BLND is from the Technology sector, while PACB is from the Healthcare sector.
5-Year PerformanceBLND has outperformed PACB, delivering a return of -37.3% compared to -46.0%
BLND vs PACB - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
BLND vs PACB - Historical Returns
Returns include dividend reinvestment.
BLND vs PACB - Annual Returns (2010 - 2026)
Returns include dividend reinvestment.
| Year | BLND | PACB |
|---|---|---|
| 2026 | -43.87% | -23.91% |
| 2025 | -20.83% | +3.89% |
| 2024 | +65.75% | -80.92% |
| 2023 | +66.67% | +23.55% |
| 2022 | -80.62% | -60.86% |
| 2021 | -64.88% | -22.43% |
| 2020 | N/A | +402.71% |
| 2019 | N/A | -30.54% |
| 2018 | N/A | +165.23% |
| 2017 | N/A | -39.45% |
| 2016 | N/A | -71.19% |
| 2015 | N/A | +68.12% |
| 2014 | N/A | +54.64% |
| 2013 | N/A | +182.70% |
| 2012 | N/A | -42.37% |
| 2011 | N/A | -82.82% |
| 2010 | N/A | -3.22% |
BLND vs PACB Drawdown Comparison
The maximum drawdown for BLND was -97.37%, occurring on May 2, 2023. This drawdown has not yet recovered.
The maximum drawdown for PACB was -98.22%, occurring on May 27, 2025. This drawdown has not yet recovered.
The current BLND drawdown is -91.89%. The current PACB drawdown is -97.26%.
| Rank | BLND | PACB |
|---|---|---|
| #1 | -97.37% Jul 16, 2021 - May 2, 2023 | -98.22% Feb 11, 2021 - May 27, 2025 |
| #2 | N/A | -93.52% Oct 28, 2010 - Dec 1, 2020 |
| #3 | N/A | -22.74% Jan 19, 2021 - Feb 10, 2021 |
| #4 | N/A | -11.19% Dec 8, 2020 - Dec 21, 2020 |
| #5 | N/A | -10.95% Dec 23, 2020 - Jan 7, 2021 |
| #6 | N/A | -9.44% Jan 8, 2021 - Jan 14, 2021 |
| #7 | N/A | -2.11% Jan 14, 2021 - Jan 19, 2021 |
Correlation
Correlation between BLND and PACB is 0.76 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks